Board of Directors

Brian is a serial entrepreneur that has extensively leveraged the SBIR program to bring ideas out of the lab and into commercialization. Brian started his career at CPI (now part of Boston Scientific) doing chip and algorithm design. He founded Data Sciences Intl, bootstrapping the company into a highly profitable business with $20m in revenue with SBIR funding (sold to Harvard Biosciences). He was a co-founder of Transoma Medical (sold to Greatbatch) and is currently CEO of VivaQuant, a commercial-stage rapidly growing provider of remote cardiac monitoring services.

Mr. Wright is a founding partner of Intercepting Horizons. As an experienced senior high-technology executive and strategist at scale, he has had the opportunity to pervade most industries and most cultures of the developed world. His experience includes both line and staff and all management levels from product to operational to c-suite, CEO, and boards. He has expertise in leadership, operations, and strategy, as well as in governance and organizational architecture.

Over the years, he has raised millions for startups and publicly traded entities and has been entrusted with the assets of nascent to large-cap technology companies. He has advised a number of the largest semiconductor equipment and materials companies in the world and led startups from his own (WWK.com) to assisting NASDAQ /Dow Jones level enterprises including GSX, August, and Rudolph Technologies (AUGT/RTEC) along with the formation and IPO of Entegris, Inc. (ENTG).

His career has been at the intersection of business, government, and academia in multiple venues, from DARPA/SEMATECH to ITRI and Fraunhofer. He enjoys innovating at the leading edges of technology from cleanrooms, filtration, and instrumentation to lithography, test and commercializing cost of ownership and capacity modeling software, and along the way developing new products, new entities, new markets, and new value propositions. He has chaired several industry organizations including: (SEMI Industry Strategy Symposium (ISS)), CONTEX, and Minnesota High Tech Association, and participated in high-level consortia, teaching both master’s degree level academic and industry-specific executive courses.

He has two patents in micro-fluidics, co-designed and developed industry-changing products, dozens of mergers and acquisitions, written over 40 articles on technology and business, and is the author of ‘The New Business Normal’ and the recently released ‘The Exponential Era’.

Patrice is Co-Chair of Fox Rothschild’s national Medical Technology practice group and serves as Administrative Partner for the Corporate Department in Minneapolis.

She advises medical technology companies, other emerging businesses, and venture capital and strategic investors in a broad range of commercial and financing matters, including: venture capital financings; private placements; mergers and acquisitions; venture debt and credit facilities; and securities compliance.

Patrice also guides lenders in commercial loan transactions and advises clients on equity financing structures and clinical trial agreements. She frequently counsel’s boards of directors on fiduciary duties and corporate governance obligations. Patrice earned her Juris Doctorate (magna cum laude, 1996) and Bachelors of Art degrees from the University of Minnesota. Patrice also contributes a Board of Director for the Minneapolis Heart Institute Foundation, Board of Directors (2018-present) and Excelen, Center for Bone & Joint Research (2010-present).

Mr. Hobday is the CEO and Founder of HealthCare Interactive, an edtech company headquartered in Minneapolis and dedicated to providing the highest quality caregiver training for Alzheimer’s disease, dementia, and other brain disorders. Mr. Hobday is an educational and instructional design expert, software developer, and dementia researcher.

He is the creator and developer of the CARES® online training, certification, and credentialing programs, all of which incorporate the trademarked CARES 5-step method to dementia care.

CARES programs are award winning, widely published in academic literature, and recognized by organizations such as the Alzheimer’s Association, American Health Care Association, National Center for Assisted Living, and the Center for Medicare and Medicaid Services (CMS). In addition, Mr. Hobday has collaborated directly with nationally known Alzheimer’s and dementia researchers at the Alzheimer’s Association, Duke University, Emory University, Michigan State University, NYU School of Medicine, University of Iowa, University of Michigan, University of Minnesota, University of South Florida, U.S. Department of Veterans Affairs, and National Institutes of Health.

Since founding HCI in 1997, Mr. Hobday has also felt the impact of dementia personally. Both of his grandmothers and his aunt have passed away with complications from Alzheimer’s disease. This has resulted in a personal commitment to improve the quality of dementia care for both familes and professional caregivers around the U.S. and Canada.

Mr. Hobday earned a B.A. Quantitative Methods/Computer Science, University of St. Thomas, St. Paul, MN (1988), a B.A. Spanish, University of St. Thomas, St. Paul, MN (1988), M.A. Education, University of St. Thomas, St. Paul, MN (1988), and a Ph.D. Business Management, Capella University, Minneapolis, MN (all coursework compete).